Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases

International Journal of Vascular Medicine

Volumn 2012, Issue , 2012, Pages

  Klop, Boudewijn ^a   Proctor, Spencer D ^b   Mamo, John C ^c   Botham, Kathleen M ^d   Castro Cabezas, Manuel ^a  

^a Center for Diabetes and Vascular Medicine   (Netherlands)

^b UNIVERSITY OF ALBERTA   (Canada)

^c CURTIN UNIVERSITY   (Australia)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; BLOOD VESSEL WALL; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CELL ADHESION; DISEASE COURSE; ENDOTHELIUM; FOAM CELL; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; INFLAMMATORY CELL; INSULIN RESISTANCE; LEUKOCYTE; LIFESTYLE; METABOLIC SYNDROME X; METABOLISM; MOLECULE; MORBIDITY; NONHUMAN; POSTPRANDIAL HYPERLIPIDEMIA; POSTPRANDIAL STATE; REVIEW;

EID: 84856989923     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2012/947417     Document Type: Review

References (136)

1. Braunwald E., Shattuck lecturecardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. New England Journal of Medicine 1997 337 19 1360 1369 2-s2.0-0030716498 10.1056/NEJM199711063371906 (Pubitemid 27467771)
2. Halkes C. J. M., Van Dijk H., De Jaegere P. P. T., Plokker H. W. M., Van der Helm Y., Erkelens D. W., Castro Cabezas M., Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 9 1526 1530 2-s2.0-0035573979 (Pubitemid 34219819)
3. Bansal S., Buring J. E., Rifai N., Mora S., Sacks F. M., Ridker P. M., Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Journal of the American Medical Association 2007 298 3 309 316 2-s2.0-34447520136 10.1001/jama.298.3.309 (Pubitemid 47080485)
4. Mora S., Rifai N., Buring J. E., Ridker P. M., Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008 118 10 993 1001 2-s2.0-52149109922 10.1161/ CIRCULATIONAHA.108.777334
5. Nordestgaard B. G., Benn M., Schnohr P., Tybjærg-Hansen A., Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Journal of the American Medical Association 2007 298 3 299 308 2-s2.0-34447511196 10.1001/jama.298.3.299 (Pubitemid 47080484)
6. Ross R., Atherosclerosisan inflammatory disease. New England Journal of Medicine 1999 340 2 115 126 2-s2.0-0033552883 10.1056/NEJM199901143400207 (Pubitemid 29054847)
7. Van Beek A. P., Van Barlingen H. H. J. J., De Ruijter-Heijstek F. C., Jansen H., Erkelens D. W., Dallinga-Thie G. M., De Bruin T. W. A., Preferential clearance of apoB-48-containing lipoproteins after heparin- induced lipolysis is modulated by lipoprotein lipase activity. Journal of Lipid Research 1998 39 2 322 332 2-s2.0-0031888669 (Pubitemid 28100670)
8. Redgrave T. G., Formation and metabolism of chylomicrons. International review of physiology 1983 28 103 130 2-s2.0-0020653918
9. Nguyen P., Leray V., Diez M., Serisier S., Le Bloc'H J., Siliart B., Dumon H., Liver lipid metabolism. Journal of Animal Physiology and Animal Nutrition 2008 92 3 272 283 2-s2.0-43449105323 10.1111/j.1439-0396.2007.00752.x (Pubitemid 351670169)
10. Castro Cabezas M., Halkes C. J. M., Meijssen S., Van Oostrom A. J. H. H. M., Erkelens D. W., Diurnal triglyceride profiles: a novel approach to study triglyceride changes. Atherosclerosis 2001 155 1 219 228 2-s2.0-0035112569 10.1016/S0021-9150(00)00554-2 (Pubitemid 32167143)
11. Van Wijk J. P. H., Castro Cabezas M., Halkes C. J. M., Erkelens D. W., Effects of different nutrient intakes on daytime triacylglycerolemia in healthy, normolipemic, free-living men. American Journal of Clinical Nutrition 2001 74 2 171 178 2-s2.0-0034928846 (Pubitemid 32702482)
12. Lewis G. F., O'Meara N. M., Soltys P. A., Blackman J. D., Iverius P. H., Pugh W. L., Getz G. S., Polonsky K. S., Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. Journal of Clinical Endocrinology and Metabolism 1991 72 4 934 944 2-s2.0-0025857172 (Pubitemid 21921788)
13. Denis McGarry J., denis.mcgarry@utsouthwestern.edu Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002 51 1 7 18 (Pubitemid 34517974)
14. Sacks F. M., Pfeffer M. A., Moye L. A., Rouleau J. L., Rutherford J. D., Cole T. G., Brown L., Warnica J. W., Arnold J. M.O., Wun C. -C., Davis B. R., Braunwald E., The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New England Journal of Medicine 1996 335 14 1001 1009 10.1056/NEJM199610033351401 (Pubitemid 26338729)
15. Downs J. R., Clearfield M., Weis S., Whitney E., Shapiro D. R., Beere P. A., Langendorfer A., Stein E. A., Kruyer W., Gotto A. M., Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Journal of the American Medical Association 1998 279 20 1615 1622 2-s2.0-0032572086 10.1001/jama.279.20.1615 (Pubitemid 28248586)
16. Tonkin A., Alyward P., Colquhoun D., Glasziou P., Harris P., Hunt D., Keech A., MacMahon S., Magnus P., Newel D., Nestel P., Sharpe N., Shaw J., Simes R. J., Thompson P., Thompson A., West M., White H., Simes S., Hague W., Caleo S., Hall J., Martin A., Mulray S., Barter P., Beilin L., Collins R., McNeil J., Meier P., Willimott H., Smithers D., Wallace P., Baker J., Hobbs M., Sullivan D., Anderson N., Hankey G., Watson J., Arulchelvam M., Chup S., Daly J., Hanna J., Leach A., Lee M., Loughhead J., Lundie-Jenkin H., Morrison J., Netting S., Nguyen A., Pater H., Philip R., Pinna G., Rattos D., Ryerson S., Sazhin V., Walsh R., Claque A., Mackie M., Yallop J., Boss K., Shepard M., Leach J., Gandy M., Joughin J., Seabrook J., Abraham R., Allen J., Bates F., Beinart I., Breed E., Brown D., Bunyan N., Calvert D., Campbell T., Condon-Paoloni D., Conway B., Coupland L., Crowe J., Cunio N., Cuthbert B., Cuthbert N., D'Arcy S., Davidson P., Dwyer B., England J., Friend C., Fulcher G., Grant S., Hellestrand K., Kava M., Kritharides L., McGill D., McKee H., McLean A., Neaverson M., Nelson G., O'Neill M., Onuma C., O'Reilly F., Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New England Journal of Medicine 1998 339 19 1349 1357 10.1056/NEJM199811053391902 (Pubitemid 28509344)
17. Collins R., Armitage J., Parish S., Sleight P., Peto R., MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002 360 9326 7 22 2-s2.0-0037031061 10.1016/S0140-6736(02)09327-3 (Pubitemid 34756487)
18. Grundy S. M., Cleeman J. I., Merz C. N., Brewer H. B., Clark L. T., Hunninghake D. B., Pasternak R. C., Smith S. C., Stone N. J., Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Journal of the American College of Cardiology 2004 44 3 720 732 2-s2.0-4544275379
19. Castro Cabezas M., De Bruin T. W. A., Kock L. A. W., Kortlandt W., Trip-M. V. L. S., Jansen H., Erkelens D. W., Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion. Metabolism 1993 42 4 497 503 2-s2.0-0027471761 10.1016/0026- 0495(93)90109-2 (Pubitemid 23112717)
20. Castro Cabezas M., Erkelens D. W., Kock L. A. W., De Bruin T. W. A., Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides. European Journal of Clinical Investigation 1994 24 10 669 678 2-s2.0-0028096947 (Pubitemid 24312523)
21. Castro Cabezas M., Verseyden C., Meijssen S., Jansen H., Erkelens D. W., Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia. Journal of Clinical Endocrinology and Metabolism 2004 89 12 5972 5980 2-s2.0-10344227176 10.1210/jc.2003-031329 (Pubitemid 39628402)
22. Van Oostrom A. J. H. H. M., Plokker H. W. M., Van Asbeck B. S., Rabelink T. J., Van Kessel K. P. M., Jansen E. H. J. M., Stehouwer C. D. A., Castro Cabezas M., Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosis. Atherosclerosis 2006 185 2 331 339 2-s2.0-33644542699 10.1016/j.atherosclerosis.2005.06.045
23. Fazio S., Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy. Clinical Therapeutics 2008 30 2 294 306 2-s2.0-41649098889 10.1016/j.clinthera.2008.02. 004 (Pubitemid 351479210)
24. Deedwania P., Barter P., Carmena R., Fruchart J. C., Grundy S. M., Haffner S., Kastelein J. J., LaRosa J. C., Schachner H., Shepherd J., Waters D. D., Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet 2006 368 9539 919 928 2-s2.0-33748303084 10.1016/S0140-6736(06) 69292-1 (Pubitemid 44331360)
25. Su J. W., Ugo Nzekwu M. M., Ball G. D. C., Proctor S. D., Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity. Journal of Clinical Lipidology 2009 3 2 78 84 2-s2.0-61949389164 10.1016/j.jacl.2009.02.006
26. Hogue J. C., Lamarche B., Tremblay A. J., Bergeron J., Gagné C., Couture P., Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. Journal of Lipid Research 2007 48 6 1336 1342 2-s2.0-34548155292 10.1194/jlr.M600548-JLR200 (Pubitemid 47312035)
27. Mamo J. C. L., Wheeler J. R., Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin. Coronary Artery Disease 1994 5 8 695 705 2-s2.0-0028068361 (Pubitemid 24302194)
28. Yu K. C. W., Mamo J. C. L., Regulation of cholesterol synthesis and esterification in primary cultures of macrophages following uptake of chylomicron remnants. Biochemistry and Molecular Biology International 1997 41 1 33 39 2-s2.0-0031040380 (Pubitemid 27090874)
29. Tomono S., Kawazu S., Kato N., Ono T., Ishii C., Ito Y., Shimizu M., Shimoyama M., Nakano T., Nakajima K., Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. Journal of atherosclerosis and thrombosis 1994 1 2 98 102 2-s2.0-0028677516
30. Batt K. V., Avella M., Moore E. H., Jackson B., Suckling K. E., Botham K. M., Differential effects of low-density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages. Experimental Biology and Medicine 2004 229 6 528 537 2-s2.0-2942525750 (Pubitemid 38736322)
31. Phillips M. L., Pullinger C., Kroes I., Kroes J., Hardman D. A., Chen G., Curtiss L. K., Gutierrez M. M., Kane J. P., Schumaker V. N., A single copy of apolipoprotein B-48 is present on the human chylomicron remnant. Journal of Lipid Research 1997 38 6 1170 1177 2-s2.0-15644373479 (Pubitemid 27281812)
32. Mamo J. C. L., Watts G. F., Barrett P. H. R., Smith D., James A. P., Sebely P. A. L., Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? American Journal of Physiology 2001 281 3 E626 E632 2-s2.0-0034823277
33. Phillips C., Murugasu G., Owens D., Collins P., Johnson A., Tomkin G. H., Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in Type 2 diabetes. Atherosclerosis 2000 148 2 283 291 2-s2.0-0033959286 10.1016/S0021-9150(99)00275-0 (Pubitemid 30064459)
34. Chan D. C., Watts G. F., Barrett P. H., Mamo J. C. L., Redgrave T. G., Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity. Clinical Chemistry 2002 48 2 278 283 2-s2.0-0036150922 (Pubitemid 34107264)
35. Cohn J. S., Marcoux C., Davignon J., Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 10 2474 2486 2-s2.0-0032858275 (Pubitemid 29477850)
36. Castro Cabezas M., Erkelens D. W., The direct way from gut to vessel wall: atheroinitiation. European Journal of Clinical Investigation 1998 28 6 504 505 2-s2.0-0031814148 10.1046/j.1365-2362.1998.00318.x (Pubitemid 28326417)
37. Dane-Stewart C. A., Watts G. F., Mamo J. C. L., Dimmitt S. B., Barrett P. H. R., Redgrave T. G., Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia. European Journal of Clinical Investigation 2001 31 2 113 117 2-s2.0-0035104868 10.1046/j.1365-2362.2001.00785.x (Pubitemid 32199903)
38. Watts G. F., Barrett P. H. R., Marais A. D., Dane-Stewart C. A., Martins I. J., Dimmitt S. B., Redgrave T. G., Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test. Atherosclerosis 2001 157 2 519 523 2-s2.0-0034905141 10.1016/S0021-9150(01) 00534-2 (Pubitemid 32710033)
39. Proctor S. D., Vine D. F., Mamo J. C. L., Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis. Current Opinion in Lipidology 2002 13 5 461 470 2-s2.0-0036773865 10.1097/00041433- 200210000-00001 (Pubitemid 35231925)
40. Proctor S. D., Vine D. F., Mamo J. C. L., Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 11 2162 2167 2-s2.0-8344262274 10.1161/01.ATV.0000143859.75035.5a (Pubitemid 39482446)
41. Goldberg I. J., Eckel R. H., McPherson R., Triglycerides and heart disease: still a hypothesis? Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 8 1716 1725 10.1161/ATVBAHA.111.226100
42. Abbott N. J., Patabendige A. A. K., Dolman D. E. M., Yusof S. R., Begley D. J., Structure and function of the blood-brain barrier. Neurobiology of Disease 2010 37 1 13 25 2-s2.0-70449529433 10.1016/j.nbd.2009.07.030
43. Yu K. C., Cooper A. D., Postprandial lipoproteins and atherosclerosis. Front Biosci 2001 6 D332 D354 2-s2.0-0035293793
44. Schaffer J. E., Lipotoxicity: when tissues overeat. Current Opinion in Lipidology 2003 14 3 281 287 2-s2.0-0038509036 10.1097/00041433-200306000-00008 (Pubitemid 36688207)
45. Ronti T., Lupattelli G., Mannarino E., The endocrine function of adipose tissue: an update. Clinical Endocrinology 2006 64 4 355 365 2-s2.0-33644911756 10.1111/j.1365-2265.2006.02474.x
46. Unger R. H., Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 1995 44 8 863 870 2-s2.0-0029151863
47. Yao P. M., Tabas I., Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. Journal of Biological Chemistry 2001 276 45 42468 42476 2-s2.0-0035834740 10.1074/jbc.M101419200 (Pubitemid 37371159)
48. Laplante M., Sabatini D. M., An emerging role of mTOR in lipid biosynthesis. Current Biology 2009 19 22 R1046 R1052 2-s2.0-70450204007 10.1016/j.cub.2009.09.058
49. Mackness B., Quarck R., Verreth W., Mackness M., Holvoet P., Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 7 1545 1550 2-s2.0-33745964245 10.1161/01.ATV.0000222924.62641.aa (Pubitemid 44288981)
50. Vaisar T., Pennathur S., Green P. S., Gharib S. A., Hoofnagle A. N., Cheung M. C., Byun J., Vuletic S., Kassim S., Singh P., Chea H., Knopp R. H., Brunzell J., Geary R., Chait A., Zhao X. Q., Elkon K., Marcovina S., Ridker P., Oram J. F., Heinecke J. W., Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. Journal of Clinical Investigation 2007 117 3 746 756 2-s2.0-33847368173 10.1172/JCI26206 (Pubitemid 46348533)
51. Tannock L. R., Chait A., Lipoprotein-matrix interactions in macrovascular disease in diabetes. Frontiers in Bioscience 2004 9 1728 1742 2-s2.0-2442675644 (Pubitemid 38918629)
52. Botham K. M., Moore E. H., De Pascale C., Bejta F., The induction of macrophage foam cell formation by chylomicron remnants. Biochemical Society Transactions 2007 35 3 454 458 2-s2.0-34250850851 10.1042/BST0350454 (Pubitemid 46975050)
53. De Pascale C., Avella M., Perona J. S., Ruiz-Gutierrez V., Wheeler-Jones C. P. D., Botham K. M., Fatty acid composition of chylomicron remnant-like particles influences their uptake and induction of lipid accumulation in macrophages. FEBS Journal 2006 273 24 5632 5640 2-s2.0-33845478773 10.1111/j.1742-4658.2006.05552.x (Pubitemid 44915888)
54. Lefer A. M., Nitric oxide: nature's naturally occurring leukocyte inhibitor. Circulation 1997 95 3 553 554 2-s2.0-0031054206 (Pubitemid 27063023)
55. Dalla-Riva J., Garonna E., Elliott J., Botham K. M., Wheeler-Jones C. P., Endothelial cells as targets for chylomicron remnants. Atherosclerosis Supplements 2010 11 1 31 37 2-s2.0-77952585827 10.1016/j.atherosclerosissup. 2010.04.001
56. Boquist S., Ruotolo G., Tang R., Björkegren J., Bond M. G., De Faire U., Karpe F., Hamsten A., Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 1999 100 7 723 728 2-s2.0-0033578450 (Pubitemid 29383642)
57. Marchesi S., Lupattelli G., Schillaci G., Pirro M., Siepi D., Roscini A. R., Pasqualini L., Mannarino E., Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. Atherosclerosis 2000 153 2 397 402 2-s2.0-0034496602 10.1016/S0021-9150(00)00415-9 (Pubitemid 32120339)
58. Vogel R. A., Corretti M. C., Plotnick G. D., Effect of a single high-fat meal on endothelial function in healthy subjects. American Journal of Cardiology 1997 79 3 350 354 2-s2.0-0031049146 10.1016/S0002-9149(96)00760-6 (Pubitemid 27093313)
59. Lefèbvre P. J., Scheen A. J., The postprandial state and risk of cardiovascular disease. Diabetic Medicine 1998 15 4 S63 S68 2-s2.0-0031794823
60. Wheeler-Jones C. P. D., Chylomicron remnants: mediators of endothelial dysfunction? Biochemical Society Transactions 2007 35 3 442 445 2-s2.0-34250869011 10.1042/BST0350442 (Pubitemid 46975047)
61. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., Gallimore J. R., Pepys M. B., Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal 2000 321 7255 199 204 2-s2.0-0034702485 (Pubitemid 30459555)
62. Friedman G. D., Klatsky A. L., Siegelaub A. B., The leukocyte count as a predictor of myocardial infarction. New England Journal of Medicine 1974 290 23 1275 1278 2-s2.0-0016385816
63. Meijssen S., Van Dijk H., Verseyden C., Erkelens D. W., Castro Cabezas M., Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 5 811 816 2-s2.0-0036097493 10.1161/01.ATV.0000014079.98335.72 (Pubitemid 34517794)
64. Muscari A., Massarelli G., Bastagli L., Poggiopollini G., Tomassetti V., Drago G., Martignani C., Pacilli P., Boni P., Puddu P., Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. European Heart Journal 2000 21 13 1081 1090 2-s2.0-0034094983 10.1053/euhj.1999.2013 (Pubitemid 30352992)
65. Schmidt M. I., Duncan B. B., Sharrett A. R., Lindberg G., Savage P. J., Offenbacher S., Azambuja M. I., Tracy R. P., Heiss G., Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999 353 9165 1649 1652 2-s2.0-0033562455 10.1016/S0140-6736(99)01046-6 (Pubitemid 29224520)
66. Verseyden C., Meijssen S., Van Dijk H., Jansen H., Castro Cabezas M., Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia. Journal of Lipid Research 2003 44 11 2100 2108 2-s2.0-0344236143 10.1194/jlr.M300201-JLR200 (Pubitemid 37509625)
67. Eriksson E. E., Xie X., Werr J., Thoren P., Lindbom L., Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB Journal 2001 15 7 1149 1157 2-s2.0-0035011098 10.1096/fj.00-0537com (Pubitemid 32436300)
68. Huo Y., Ley K., Adhesion molecules and atherogenesis. Acta Physiologica Scandinavica 2001 173 1 35 43 2-s2.0-0034798250 10.1046/j.1365-201X.2001.00882.x (Pubitemid 32948331)
69. Murohara T., Buerke M., Lefer A. M., Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction: role of selectins. Arteriosclerosis and Thrombosis 1994 14 9 1509 1519 2-s2.0-0028168232
70. Worthylake R. A., Burridge K., Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Current Opinion in Cell Biology 2001 13 5 569 577 2-s2.0-0035479822 10.1016/S0955-0674(00)00253-2 (Pubitemid 32817015)
71. Van Oostrom A. J. H. H. M., Sijmonsma T. P., Rabelink T. J., Van Asbeck B. S., Castro Cabezas M., Postprandial leukocyte increase in healthy subjects. Metabolism 2003 52 2 199 202 2-s2.0-0037303458 10.1053/meta.2003.50037 (Pubitemid 36388843)
72. Van Oostrom A. J. H. H. M., Sijmonsma T. P., Verseyden C., Jansen E. H. J. M., De Koning E. J. P., Rabelink T. J., Cabezas M. C., Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. Journal of Lipid Research 2003 44 3 576 583 2-s2.0-0038620491 10.1194/jlr.M200419-JLR200 (Pubitemid 37279707)
73. Wanten G., Van Emst-de Vries S., Naber T., Willems P., Nutritional lipid emulsions modulate cellular signaling and activation of human neutrophils. Journal of Lipid Research 2001 42 3 428 436 2-s2.0-0035063558 (Pubitemid 32270067)
74. Bentley C., Hathaway N., Widdows J., Bejta F., De Pascale C., Avella M., Wheeler-Jones C. P. D., Botham K. M., Lawson C., Influence of chylomicron remnants on human monocyte activation in vitro. Nutrition, Metabolism and Cardiovascular Diseases. In press 2-s2.0-77954987942 10.1016/j.numecd.2010.02. 019
75. Hiramatsu K., Arimori S., Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes 1988 37 6 832 837 2-s2.0-0024244297 (Pubitemid 19043196)
76. Van Oostrom A. J. H. H. M., Rabelink T. J., Verseyden C., Sijmonsma T. P., Plokker H. W. M., De Jaegere P. P. T., Cabezas M. C., Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 2004 177 1 175 182 2-s2.0-5444256832 10.1016/j.atherosclerosis.2004.07.004 (Pubitemid 39361153)
77. Tertov V. V., Kalenich O. S., Orekhov A. N., Lipid-laden white blood cells in the circulation of patients with coronary heart disease. Experimental and Molecular Pathology 1992 57 1 22 28 2-s2.0-0026443786 10.1016/0014-4800(92) 90045-D
78. Skrede B., Blomhoff R., Maelandsmo G. M., Ose L., Myklebost O., Norum K. R., Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo. European Journal of Clinical Investigation 1992 22 4 229 234 2-s2.0-0026550907
79. Alipour A., Van Oostrom A. J. H. H. M., Izraeljan A., Verseyden C., Collins J. M., Frayn K. N., Plokker T. W. M., Elte J. W. F., Cabezas M. C., Leukocyte activation by triglyceride-rich lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 4 792 797 2-s2.0-42249089376 10.1161/ATVBAHA.107.159749 (Pubitemid 351651339)
80. Cianflone K., Xia Z., Chen L. Y., Critical review of acylation- stimulating protein physiology in humans and rodents. Biochimica et Biophysica Acta 2003 1609 2 127 143 2-s2.0-0037473998 10.1016/S0005-2736(02)00686-7 (Pubitemid 36120719)
81. van Oostrom A. J. H. H. M., Alipour A., Plokker T. W. M., Sniderman A. D., Castro Cabezas M., The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers. Atherosclerosis 2007 190 1 167 173 2-s2.0-33845463273 10.1016/j.atherosclerosis.2006.01.009 (Pubitemid 44908311)
82. Torzewski J., Torzewski M., Bowyer D. E., Fröhlich M., Koenig W., Waltenberger J., Fitzsimmons C., Hombach V., C-Reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 9 1386 1392 2-s2.0-0031668698 (Pubitemid 28421875)
83. Griselli M., Herbert J., Hutchinson W. L., Taylor K. M., Sohail M., Krausz T., Pepys M. B., C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. Journal of Experimental Medicine 1999 190 12 1733 1739 2-s2.0-0033396705 10.1084/jem.190.12.1733 (Pubitemid 30013840)
84. Scantlebury T., Sniderman A. D., Cianflone K., Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. Biochemical Journal 2001 356 2 445 452 2-s2.0-0035365875 10.1042/0264-6021: 3560445 (Pubitemid 32532355)
85. Halkes C. J. M., Van Dijk H., Verseyden C., De Jaegere P. P. T., Plokker H. W. M., Meijssen S., Erkelens D. W., Castro Cabezas M., Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 10 1875 1880 2-s2.0-0141988894 10.1161/01.ATV. 0000092326.00725.ED (Pubitemid 37254878)
86. Laakso M., Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West award lecture 2008. Diabetes Care 2010 33 2 442 449 2-s2.0-75149129619 10.2337/dc09-0749
87. Laakso M., Insulin resistance and coronary heart disease. Current Opinion in Lipidology 1996 7 4 217 226 2-s2.0-0029760006 (Pubitemid 26280231)
88. Ruige J. B., Assendelft W. J. J., Dekker J. M., Kostense P. J., Heine R. J., Bouter L. M., Insulin and risk of cardiovascular disease: a meta-analysis. Circulation 1998 97 10 996 1001 2-s2.0-0032539895 (Pubitemid 28125472)
89. Mottillo S., Filion K. B., Genest J., Joseph L., Pilote L., Poirier P., Rinfret S., Schiffrin E. L., Eisenberg M. J., The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. Journal of the American College of Cardiology 2010 56 14 1113 1132 2-s2.0-77957198071 10.1016/j.jacc.2010.05.034
90. Alexander C. M., Landsman P. B., Teutsch S. M., Haffner S. M., NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003 52 5 1210 1214 2-s2.0-0037407403 10.2337/diabetes.52.5.1210 (Pubitemid 36523358)
91. Koskinen J., Kähönen M., Viikari J. S. A., Taittonen L., Laitinen T., Rönnemaa T., Lehtimäki T., Hutri-Kähönen N., Pietikäinen M., Jokinen E., Helenius H., Mattsson N., Raitakari O. T., Juonala M., Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young finns study. Circulation 2009 120 3 229 236 2-s2.0-67651089516 10.1161/CIRCULATIONAHA.108.845065
92. Moller D. E., Kaufman K. D., Metabolic syndrome: a clinical and molecular perspective. Annual Review of Medicine 2005 56 45 62 2-s2.0-13544253065 10.1146/annurev.med.56.082103.104751 (Pubitemid 40299773)
93. Eckel R. H., Grundy S. M., Zimmet P. Z., The metabolic syndrome. Lancet 2005 365 9468 1415 1428 2-s2.0-17144380822 10.1016/S0140-6736(05)66378-7 (Pubitemid 40523737)
94. Alberti K. G. M. M., Zimmet P., Shaw J., The metabolic syndromea new worldwide definition. Lancet 2005 366 9491 1059 1062 2-s2.0-25144459980 10.1016/S0140-6736(05)67402-8 (Pubitemid 41338752)
95. Sullivan D. R., Celermajer D. S., Le Couteur D. G., Lam C. W., The vascular implications of post-prandial lipoprotein metabolism. Clinical Biochemistry Reviews 2004 25 1 19 30
96. Lopez-Miranda J., Williams C., Larion D., Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. British Journal of Nutrition 2007 98 3 458 473 2-s2.0-34547965706 10.1017/S000711450774268X (Pubitemid 47272862)
97. Lairon D., denis.lairon@univmed.fr Defoort C., Effects of nutrients on postprandial lipemia. Current Vascular Pharmacology 2011 9 3 309 312 10.2174/157016111795495576
98. Bravo E., Napolitano M., Botham K. M., Postprandial lipid metabolism: the missing link between life-style habits and the increasing incidence of metabolic diseases in western countries? Open Translational Medicine Journal 2010 2 1 13 2-s2.0-77955165542 10.2174/1876399501002010001
99. Dubois C., Beaumier G., Juhel C., Armand M., Portugal H., Pauli A. M., Borel P., Latgé C., Lairon D., Effects of graded amounts (050 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults. American Journal of Clinical Nutrition 1998 67 1 31 38 2-s2.0-0031975290 (Pubitemid 28037622)
100. Sharrett A. R., Heiss G., Chambless L. E., Boerwinkle E., Coady S. A., Folsom A. R., Patsch W., Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides the Atherosclerosis Risk in Communities (ARIC) study. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 2 275 281 2-s2.0-0035146363 (Pubitemid 32125378)
101. Lairon D., Play B., Jourdheuil-Rahmani D., Digestible and indigestible carbohydrates: interactions with postprandial lipid metabolism. Journal of Nutritional Biochemistry 2007 18 4 217 227 2-s2.0-33847796797 10.1016/j.jnutbio.2006.08.001 (Pubitemid 46389579)
102. Zampelas A., Peel A. S., Gould B. J., Wright J., Williams C. M., Polyunsaturated fatty acids of the n-6 and n-3 series: effects on postprandial lipid and apolipoprotein levels in healthy men. European Journal of Clinical Nutrition 1994 48 12 842 848 2-s2.0-0028566420
103. Williams C. M., Moore F., Morgan L., Wright J., Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects. British Journal of Nutrition 1992 68 3 655 666 2-s2.0-0027104290 10.1079/BJN19920123 (Pubitemid 23027126)
104. Harris W. S., Muzio F., Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates. American Journal of Clinical Nutrition 1993 58 1 68 74 2-s2.0-0027233887 (Pubitemid 23193236)
105. Kelley D. S., Siegel D., Vemuri M., Mackey B. E., Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. American Journal of Clinical Nutrition 2007 86 2 324 333 2-s2.0-34547879709 (Pubitemid 47256914)
106. Westphal S., Orth M., Ambrosch A., Osmundsen K., Luley C., Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids. American Journal of Clinical Nutrition 2000 71 4 914 920 2-s2.0-0034066758 (Pubitemid 30176573)
107. Lairon D., Macronutrient intake and modulation on chylomicron production and clearance. Atherosclerosis Supplements 2008 9 2 45 48 2-s2.0-50849100711 10.1016/j.atherosclerosissup.2008.05.006
108. Lozano A., Perez-Martinez P., Delgado-Lista J., Body mass interacts with fat quality to determine the postprandial lipoprotein response in healthy young adults. Nutrition, Metabolism and Cardiovascular Disease. In press
109. Mortensen L. S., Hartvigsen M. L., Brader L. J., Astrup A., Schrezenmeir J., Holst J. J., Thomsen C., Hermansen K., Differential effects of protein quality on postprandial lipemia in response to a fat-rich meal in type 2 diabetes: comparison of whey, casein, gluten, and cod protein. American Journal of Clinical Nutrition 2009 90 1 41 48 2-s2.0-67649855083 10.3945/ajcn.2008.27281
110. Khossousi A., Binns C. W., Dhaliwal S. S., Pal S., The acute effects of psyllium on postprandial lipaemia and thermogenesis in overweight and obese men. British Journal of Nutrition 2008 99 5 1068 1075 2-s2.0-53049100606 10.1017/S0007114507864804
111. Harbis A., Perdreau S., Vincent-Baudry S., Charbonnier M., Bernard M. C., Raccah D., Senft M., Lorec A. M., Defoort C., Portugal H., Vinoy S., Lang V., Lairon D., Glycemic and insulinemic meal responses modulate postprandial hepatic and intestinal lipoprotein accumulation in obese, insulin-resistant subjects. American Journal of Clinical Nutrition 2004 80 4 896 902 2-s2.0-5144232464 (Pubitemid 41202088)
112. Livesey G., Taylor R., Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. American Journal of Clinical Nutrition 2008 88 5 1419 1437 2-s2.0-55849086887 10.3945/ajcn.2007.25700
113. Mente A., De Koning L., Shannon H. S., Anand S. S., A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Archives of Internal Medicine 2009 169 7 659 669 2-s2.0-65249102362 10.1001/archinternmed.2009.38
114. Basu A., Lucas E. A., Mechanisms and effects of green tea on cardiovascular health. Nutrition Reviews 2007 65 8 361 375 2-s2.0-34948894467 10.1301/nr.2007.aug.361-375 (Pubitemid 351804352)
115. Burton-Freeman B., Linares A., Hyson D., Kappagoda T., Strawberry modulates LDL oxidation and postprandial lipemia in response to high-fat meal in overweight hyperlipidemic men and women. Journal of the American College of Nutrition 2010 29 1 46 54 2-s2.0-77956471340
116. Abia R., Pacheco Y. M., Perona J. S., Montero E., Muriana F. J. G., Ruiz-Gutiérrez V., The metabolic availability of dietary triacylglycerols from two high oleic oils during the postprandial period does not depend on the amount of oleic acid ingested by healthy men. Journal of Nutrition 2001 131 1 59 65 2-s2.0-0035188011 (Pubitemid 32060623)
117. Castro Cabezas M., de Vries J. H. M., Van Oostrom A. J. H. H. M., Iestra J., van Staveren W. A., Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins. Journal of the American Dietetic Association 2006 106 10 1564 1569 2-s2.0-33748808090 10.1016/j.jada.2006.07.009 (Pubitemid 44415592)
118. Braun L. T., Cholesterol and triglyceride management: If i take my medication, can I Eat what I Want? Journal of Cardiovascular Nursing 2010 25 3 241 246 2-s2.0-77951031539 10.1097/JCN.0b013e3181cec6d1
119. Maraki M., Magkos F., Christodoulou N., Aggelopoulou N., Skenderi K. P., Panagiotakos D., Kavouras S. A., Sidossis L. S., One day of moderate energy deficit reduces fasting and postprandial triacylglycerolemia in women: the role of calorie restriction and exercise. Clinical Nutrition 2010 29 4 459 463 2-s2.0-77955269565 10.1016/j.clnu.2009.10.007
120. Maraki M. I., Aggelopoulou N., Christodoulou N., Anastasiou C. A., Toutouza M., Panagiotakos D. B., Kavouras S. A., Magkos F., Sidossis L. S., lsidossis@hua.gr Lifestyle intervention leading to moderate weight loss normalizes postprandial triacylglycerolemia despite persisting obesity. Obesity 2011 19 5 968 976 10.1038/oby.2010.218
121. MacEneaney O. J., Harrison M., O'Gorman D. J., Pankratieva E. V., O'Connor P. L., Moyna N. M., Effect of prior exercise on postprandial lipemia and markers of inflammation and endothelial activation in normal weight and overweight adolescent boys. European Journal of Applied Physiology 2009 106 5 721 729 2-s2.0-67650327845 10.1007/s00421-009-1073-y
122. Pafili Z. K., Bogdanis G. C., Tsetsonis N. V., Maridaki M., Postprandial lipemia 16 and 40 hours after low-volume eccentric resistance exercise. Medicine and Science in Sports and Exercise 2009 41 2 375 382 2-s2.0-65449120654 10.1249/MSS.0b013e31818703ec
123. Dekker M. J., Graham T. E., Ooi T. C., Robinson L. E., Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men. Journal of Nutritional Biochemistry 2010 21 10 983 990 2-s2.0-77956652380 10.1016/j.jnutbio.2009.08.004
124. Miyashita M., Burns S. F., Stensel D. J., Acute effects of accumulating exercise on postprandial lipemia and C-reactive protein concentrations in young men. International Journal of Sport Nutrition and Exercise Metabolism 2009 19 6 569 582 2-s2.0-71949083401
125. Gavin C., Sigal R. J., Cousins M., Menard M. L., Atkinson M., Khandwala F., Kenny G. P., Proctor S., Ooi T. C., Resistance exercise but not aerobic exercise lowers remnant-like lipoprotein particle cholesterol in type 2 diabetes: a randomized controlled trial. Atherosclerosis 2010 213 2 552 557 2-s2.0-78649751258 10.1016/j.atherosclerosis.2010.08.071
126. Singhal A., Trilk J. L., Jenkins N. T., Bigelman K. A., Cureton K. J., Effect of intensity of resistance exercise on postprandial lipemia. Journal of Applied Physiology 2009 106 3 823 829 2-s2.0-64349124700 10.1152/japplphysiol. 90726.2008
127. Murphy M. H., Blair S. N., Murtagh E. M., Accumulated versus continuous exercise for health benefit: a review of empirical studies. Sports Medicine 2009 39 1 29 43 2-s2.0-57749181993 10.2165/00007256-200939010-00003
128. Bloomer R. J., Fisher-Wellman K. H., Postprandial oxidative stress in exercise trained and sedentary cigarette smokers. International Journal of Environmental Research and Public Health 2009 6 2 579 591 2-s2.0-61449186583 10.3390/ijerph6020579
129. Bloomer R. J., Fisher-Wellman K. H., Bell H. K., The effect of long-term, high-volume aerobic exercise training on postprandial lipemia and oxidative stress. Physician and Sportsmedicine 2010 38 1 64 71 2-s2.0-77950815376 10.3810/psm.2010.04.1763
130. O'Keefe J. H., Gheewala N. M., O'Keefe J. O., Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. Journal of the American College of Cardiology 2008 51 3 249 255 2-s2.0-38149027125 10.1016/j.jacc.2007.10.016
131. Naissides M., Mamo J. C. L., James A. P., Pal S., The effect of acute red wine polyphenol consumption on postprandial lipaemia in postmenopausal women. Atherosclerosis 2004 177 2 401 408 2-s2.0-8644275566 10.1016/j.atherosclerosis. 2004.07.025 (Pubitemid 39505274)
132. Mero N., Syvanne M., Eliasson B., Smith U., Taskinen M. R., Postprandial elevation of apoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 10 2096 2102 2-s2.0-0031440816 (Pubitemid 28057113)
133. Meijssen S., Derksen R. J., Bilecen S., Erkelens D. W., Castro Cabezas M., In vivo modulation of plasma free fatty acids in patients with Familial Combined Hyperlipidemia using Lipid-Lowering medication. Journal of Clinical Endocrinology and Metabolism 2002 87 4 1576 1580 2-s2.0-0036281385 10.1210/jc.87.4.1576 (Pubitemid 34615242)
134. Ford E. S., Li C., Zhao G., Pearson W. S., Mokdad A. H., Hypertrigly ceridemia and Its pharmacologic treatment among US adults. Archives of Internal Medicine 2009 169 6 572 578 2-s2.0-63849198178 10.1001/archinternmed.2008.599
135. Jun M., Foote C., Lv J., Neal B., Patel A., Nicholls S. J., Grobbee D. E., Cass A., Chalmers J., Perkovic V., Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. The Lancet 2010 375 9729 1875 1884 2-s2.0-77952708442 10.1016/S0140-6736(10)60656-3
136. Van Wijk J. P. H., Hoepelman A. I. M., De Koning E. J. P., Dallinga-Thie G., Rabelink T. J., Castro Cabezas M., Differential effects of rosiglitazone and metformin on postprandial lipemia in patients with HIV-lipodystrophy. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 1 228 233 2-s2.0-78650885879 10.1161/ATVBAHA.110.216192